|
ZFYVE20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74320000001504E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.39720000000587E-06 |
| Normal-vs-Stage2 |
5.264200E-02 |
| Normal-vs-Stage3 |
5.563400E-04 |
| Normal-vs-Stage4 |
1.255130E-03 |
| Stage1-vs-Stage2 |
8.468600E-01 |
| Stage1-vs-Stage3 |
3.055800E-01 |
| Stage1-vs-Stage4 |
1.640780E-01 |
| Stage2-vs-Stage3 |
3.875400E-01 |
| Stage2-vs-Stage4 |
1.942600E-01 |
| Stage3-vs-Stage4 |
5.032200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.22030000002405E-06 |
| Normal-vs-AfricanAmerican |
3.174400E-04 |
| Normal-vs-Asian |
1.6848099999911E-05 |
| Caucasian-vs-AfricanAmerican |
7.612800E-01 |
| Caucasian-vs-Asian |
2.405200E-01 |
| AfricanAmerican-vs-Asian |
2.616600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00849999462582E-08 |
| Normal-vs-Female |
4.393200E-01 |
| Male-vs-Female |
1.163610E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.604370E-04 |
| Normal-vs-Extreme_Weight |
1.8243999999612E-07 |
| Normal-vs-Obese |
5.863900E-03 |
| Normal-vs-Extreme_Obese |
2.850300E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.641600E-01 |
| Normal_Weight-vs-Obese |
1.993620E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.396400E-01 |
| Extreme_Weight-vs-Obese |
6.516300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.564400E-01 |
| Obese-vs-Extreme_Obese |
2.751400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.475520E-02 |
| Normal-vs-Age(41-60Yrs) |
3.643000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.00589999996181E-07 |
| Normal-vs-Age(81-100Yrs) |
9.801800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.410000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.307600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.305000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.942000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.820000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.510600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.616340E-04 |
| Normal-VS-Type2 PRCC |
4.84399997890961E-09 |
| Normal-VS-KIRP CIMP |
2.730200E-01 |
| Normal-VS-Unclassified PRCC |
3.166200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.017600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.357800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.128600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.030100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.317700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.912800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77509995591407E-09 |
| Normal-vs-N1 |
9.318200E-03 |
| Normal-vs-N2 |
1.550990E-01 |
| N0-vs-N1 |
3.557000E-01 |
| N0-vs-N2 |
9.618200E-01 |
| N1-vs-N2 |
6.710000E-01 |
|
|
